An actinic keratosis can feel like sandpaper before it becomes obvious in a mirror. Because some develop into squamous cell carcinoma, suspected lesions should be assessed and treated.
Actinic keratosis (AK) is a rough or scaly patch caused by cumulative ultraviolet damage, usually on the face, scalp, ears, forearms or backs of hands. It is considered precancerous because some lesions progress to squamous cell carcinoma.
AKs develop in the outer layer of skin after years of sun or tanning-bed exposure. A person may have one visible lesion or a broader “field” of sun-damaged skin containing multiple subtle areas. The number and behavior of individual lesions can change over time.
You cannot reliably distinguish an AK from early squamous cell carcinoma using a photograph. A clinician should examine suspected lesions, particularly when they become thick, tender, rapidly larger or ulcerated.
A dermatologist may treat a single lesion with cryosurgery or address a wider field using prescription creams, photodynamic therapy or other procedures. Common prescription field treatments include 5-fluorouracil, imiquimod, diclofenac and tirbanibulin; each has different schedules, reactions and contraindications.
Do not borrow another person's prescription or apply wart remover. Protect treated and untreated skin with shade, clothing and broad-spectrum sunscreen. New lesions remain possible because treatment removes visible damage, not the lifetime UV exposure behind it.
Most individual AKs do not become invasive cancer, but clinicians cannot predict perfectly which will progress. Having AKs also signals substantial UV damage and a higher overall risk of keratinocyte skin cancers. That is why dermatology organizations recommend assessment and treatment rather than indefinite home observation.
Schedule regular skin checks at the interval your clinician recommends, and perform self-exams between visits. Any lesion that evolves faster than the surrounding sun-damaged spots deserves earlier review.
We use established public-health and dermatology references and link them directly so you can verify the guidance and read further.
It is considered precancerous, not invasive cancer. Some lesions can develop into squamous cell carcinoma, and it is not possible to know which ones will progress.
Often rough, gritty or sandpaper-like. You may feel it before you see a clear color change.
Some appear to fade, but they can return and new lesions can develop. Suspected AKs should still be assessed because early skin cancer may look similar.
No standard over-the-counter product reliably treats AK. Diagnosis and treatment should be clinician-directed.
Use shade, protective clothing, broad-spectrum SPF 30+ sunscreen and avoid tanning beds. Continue regular skin checks because past UV damage cannot be reversed.
Use RashScan for educational triage, then arrange an exam for any persistent sun-damaged lesion.
Assess a rough skin patchEducational guidance only — not a medical diagnosis.